United States Artemisinin API Market was valued at USD 0.13 Billion in 2022 and is projected to reach USD 0.29 Billion by 2030, growing at a CAGR of 9.8% from 2024 to 2030.
Start
The Us Artemisinin Api Market Has Been Experiencing Significant Growth, Driven By A Surge In Demand From The Pharmaceutical And Biotechnology Industries. Artemisinin, Derived From The Plant *Artemisia Annua*, Is A Key Component In The Treatment Of Malaria, One Of The Most Pressing Global Health Concerns. As The Demand For Anti-Malarial Drugs Continues To Rise, The Requirement For Artemisinin Api (Active Pharmaceutical Ingredient) Is Poised For Further Expansion In The Us Market.
One Of The Primary Drivers Of This Demand Is The Increasing Global Prevalence Of Malaria, Especially In Developing Regions Where The Disease Remains Endemic. Artemisinin-Based Combination Therapies (Acts) Are Considered The Gold Standard For Malaria Treatment, And The Continued Reliance On These Drugs Ensures A Robust Market For Artemisinin Apis. In Addition, The Rise Of Resistance To Other Anti-Malarial Drugs Has Made Artemisinin-Based Treatments Even More Critical, Further Driving Demand In The Pharmaceutical Sector.
The Us Pharmaceutical Industry Plays A Pivotal Role In Global Healthcare, And It Is One Of The Largest Importers Of Artemisinin Apis. The Increasing Adoption Of Artemisinin For Non-Malaria Indications, Including Cancer Treatment, Has Also Spurred The Need For Larger Quantities Of This Api. Furthermore, The Ongoing Research Into The Potential Therapeutic Applications Of Artemisinin In Other Diseases, Such As Tuberculosis, Is Contributing To Market Growth.
With The Expansion Of The Artemisinin Market, Manufacturers Are Focusing On Increasing Production Capacities And Improving The Efficiency Of Extraction Processes. This, In Turn, Reduces The Cost Of Artemisinin Apis, Making It More Accessible To Pharmaceutical Companies Worldwide. Additionally, The Regulatory Landscape In The Us Plays A Significant Role In Ensuring The Quality And Safety Of Artemisinin-Based Products, Reinforcing The Need For High-Quality, Reliable Api Sources.
The Requirement For Artemisinin Apis Is Also Driven By Industry-Specific Factors Such As The Growth Of Biotechnology Firms, The Rise Of Contract Manufacturing Organizations (Cmos), And The Increasing Demand For Generic Malaria Treatments. In Line With This, The Market Is Expected To Grow At A Steady Pace, With A Promising Future For Both Manufacturers And End-Users In The Pharmaceutical Industry.
The Dynamics Of The Artemisinin Api Market Closely Mirror Trends Seen In Other Specialized Markets, Such As The 100 Gigabit Fiber Optic Transceiver Market Type And Requirement From Industries. As Both Markets Share Similar Patterns In Technological Advancement And Industry-Specific Needs, Stakeholders In These Sectors Continue To Seek Innovative Solutions To Meet The Evolving Demand.
Get an In-Depth Research Analysis of the US Artemisinin API Market Size And Forecast [2025-2032]
Sanofi
KPC Pharmaceuticals
Kerui nanhai
Guangxi xiancaotang
Guilin Pharmaceutical
Natural Bio-engineering
BIONEXX
CAT KHANH
BEEPZ
Novanat Bioresource
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Artemisinin API Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Artemisinin API Market
Natural Sources
Synthetic Production
Semi-Synthetic Pathways
Antimalarial Medications
Combination Therapies
Research and Development
Injectable Formulations
Oral Formulations
Topical Formulations
Pharmaceutical Companies
Research Institutes
Contract Manufacturing Organizations
Direct Sales
Online Retail
Distributors and Wholesalers
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Artemisinin API Market Research Analysis
1. Introduction of the US Artemisinin API Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Artemisinin API Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Artemisinin API Market, By Type
6. US Artemisinin API Market, By Application
7. US Artemisinin API Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Artemisinin API Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/